We welcome eleven new pathology residency applicants with a variety of academic career goals in AP/CP, AP/NP, and CP only.
Read more
Paper identifies genome refolding that drives epigenetic adaptation and could also drive resistance to targeted therapy in T cell leukemia.
Read more
The Department mourns the loss of our esteemed colleague, mentor, and friend John Trojanowski, MD, PhD, one of the foremost pioneers in the field of neuroscience, neuropathology and neurodegenerative diseases.
Read more
Center for Artificial Intelligence and Data Science for Integrated Diagnostics (AI2D) is a highly collaborative effort across School of Medicine Departments with focus on AI-driven integrated diagnostics, and was seeded by the emerging Integrated Diagnostics Program co-led by the Department of Radiology and the Department of Pathology and Laboratory Medicine.
Read more
Report in Nature analyzes CAR T cell therapy against chronic lymphocytic leukemia in first two patients with sustained remission a decade after infusion.
Read more
Recognized for her distinguished contributions to the field of virology and the development of novel technologies used to identify new pathways in and treatment of virus-induced diseases.
Read more
Dr. Wolk, director of the Penn Alzheimer’s Disease Research Center and co-director of the Penn Memory Center, is Professor of Neurology and Chief of the Division of Cognitive Neurology. Dr. Lee, who is the Penn ADRC co-associate director, is an Associate Professor in the Department of Pathology and Laboratory Medicine.
Read more
Dr. Sara Cherry in the New York Times on antiviral drugs against coronavirus, Pfizer's COVID-19 pill, and omicron-variant transmissibility; Dr. Don Siegel's Vetigenics Penn Center for Innovation Start-Up of the Year; Dr. Vijay Bhoj part of a clinical trail research team awarded $14M NIH grant for organ transplantation with CAR T-Cell therapy.
Read more
Center for Neurodegenerative Disease Research (CNDR) brain bank archives its 2000th case.
Read more
Nature paper by Davidson lab describes regulated control of gene therapies by drug-induced splicing, NHGRI R35 Genomic Innovator Award for Dr. Chesi, Dr. Stephen Master begins term as president of the American Association for Clinical Chemistry (AACC), Dr. Don Siegel receives AABB Award for pioneering use of chimeric antigen receptor T cell constructs, Dr. Ping Wang selected to be a member of the Clinical Chemistry and Clinical Toxicology Devices Panel at the FDA, and Dr. George Xu part of $11.7 million NCI SPORE grant.
Read more
Pages
